Kansas City Cancer Center KCCC (3) — Overland Park, Kansas

Kansas City Cancer Center KCCC (3) is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Kansas City Cancer Center KCCC (3) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer Center KCCC (3)?

Kansas City Cancer Center KCCC (3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer Center KCCC (3) conducted?

Kansas City Cancer Center KCCC (3) has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is Kansas City Cancer Center KCCC (3) accredited by Crixeo Health?

Kansas City Cancer Center KCCC (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Cancer Center KCCC (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.